Cleared Traditional

K062979 - THYROSAMPLER

K062979 is an FDA 510(k) clearance for THYROSAMPLER, manufactured by Acd Medical Innovation Corp.. The device is a Class 2 Gastroenterology & Urology device with product code FCG cleared through the Traditional 510(k) pathway after a 243-day FDA review.

K062979 · Acd Medical Innovation Corp. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2007
Decision
243d
Days
Class 2
Risk

K062979 is an FDA 510(k) clearance for the THYROSAMPLER. Classified as Biopsy Needle (product code FCG), Class II - Special Controls.

Submitted by Acd Medical Innovation Corp. (Littleton, US). The FDA issued a Cleared decision on May 30, 2007 after a review of 243 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Acd Medical Innovation Corp. devices

FDA 510(k) Submission Details - K062979

510(k) Number K062979 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2006
Decision Date May 30, 2007
Days to Decision 243 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
112d slower than avg
Panel avg: 131d · This submission: 243d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FCG Device Classification - Class 2, Special Controls

Product Code FCG Biopsy Needle
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FCG Biopsy Needle

All 92
Devices cleared under the same product code (FCG) and FDA review panel - the closest regulatory comparables to K062979.
ECHOTIP ULTRA ULTRASOUND NEEDLE
K083330 · Cook Endoscopy · Feb 2009
BIOPSY GUIDE KIT FOR 8808 AND BIPLANE, ENDFIRE AND DUAL BIOPSY GUIDES FOR 8818
K081323 · B-K Medical Aps · Jul 2008
TARGETSCAN BIOPSY KIT, TARGETSCAN BIOPSY NEEDLE GUIDE
K073399 · Envisioneering, LLC · Dec 2007
TROKABONE, TROKABONE STERNAL
K070179 · PAJUNK GmbH Medizintechnologie · Mar 2007
SONOTIP II ULTRASOUND NEEDLE SYSTEM
K070129 · Medi-Globe Corporation · Jan 2007
MIELO-CAN, BEST-LISAS, BEN - BONE BIOPSY. FAST-CUT, COLT, SPRING-CUT, BIO-CUT - SOFT TISSUE BIOPSY
K051506 · Sterylab S.R.L. · Jul 2005